ERBB2 and invasive carcinoma: Consistent with this model, the elevated frequency at which nucleocytoplasmic ß-catenin was detected in human DCIS specimens compared with invasive carcinomas in our study could reflect the relatively high frequency of HER2/neu overexpression in human DCIS lesions compared with frank cancers [70]–[72].